GlaxoSmithKline hid Avandia data

For GlaxoSmithKline, it just gets worse and worse.  According to the New York Times, GSK tested Avandia against a competing drug in 1999.  But the study showed that Avandia performed worse and was riskier to the heart.  So GSK buried the data for 11 years and failed to post the study on a federal web site, as the law requires.  It makes you wonder what the GSK bioethics consultant is thinking.